文献速递瓣膜外科

多枚MitraClip:压力梯度与反流之间的平衡

Multiple MitraClips: The balancing act between pressure gradient and regurgitation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-05-31

本研究利用猪二尖瓣体外左心模拟器,评估使用多枚MitraClip治疗二尖瓣反流时对瓣膜性能的影响。结果显示,1枚或2枚MitraClip均能显著降低反流分数且未显著升高二尖瓣跨瓣压差,但2枚相比1枚并未进一步显著降低反流分数。

要点

  • 1枚或2枚MitraClip均可显著降低二尖瓣反流分数且不显著升高跨瓣压差。
  • 2枚MitraClip相比1枚并未进一步显著降低反流分数。
  • 体外模型提示多枚MitraClip在降低反流与避免压差升高间取得平衡。

核心结论

  • 使用1枚或2枚MitraClip降低二尖瓣反流时,跨瓣压差升高风险有限。
  • 2枚MitraClip并未比1枚进一步显著降低反流分数。

研究设计与样本

  • 研究采用6个猪二尖瓣在体外左心模拟器中进行测试。
  • 测试条件包括原生状态、中重度反流和重度反流。
  • 反流病例分别测试无MitraClip、1枚MitraClip和2枚MitraClip配置。

主要发现

  • 原生状态下反流分数为14.22%,跨瓣压差为2.59 mm Hg,有效瓣口面积为1.64 cm2。
  • 中重度反流无MitraClip时反流分数为34.07%,跨瓣压差为3.31 mm Hg,有效瓣口面积为2.22 cm2。
  • 中重度反流中,1枚MitraClip将反流分数降至18.57%(P < .0001),有效瓣口面积降至1.50 cm2(P = .0002),跨瓣压差为3.44 mm Hg(无统计学变化)。
  • 中重度反流中,2枚MitraClip将反流分数降至14.26%(P < .0001),有效瓣口面积降至1.36 cm2(P = .0001),跨瓣压差为3.29 mm Hg(无统计学变化)。
  • 重度反流无MitraClip时反流分数为59.79%,跨瓣压差为4.98 mm Hg,有效瓣口面积为2.73 cm2;1枚MitraClip将反流分数降至30.72%(P < .0001),有效瓣口面积降至1.82 cm2(P < .0001),跨瓣压差为4.03 mm Hg(无统计学变化);2枚MitraClip将反流分数降至23.10%(P < .0001),有效瓣口面积降至1.58 cm2(P < .0001),跨瓣压差为3.82 mm Hg(无统计学变化)。

临床怎么用

  • 体外模拟结果提示,在减少二尖瓣反流时可优先考虑使用1枚MitraClip,因增加至2枚未见额外显著降低反流分数。
  • 临床决策中需权衡反流降低与跨瓣压差升高风险,但本研究中压差未见显著升高。

局限性

  • 研究仅基于6个猪二尖瓣的体外模拟,不能完全代表人体生理和病理状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Transcatheter mitral valve repair with the MitraClip is used for the symptomatic management of mitral regurgitation (MR). The challenge is reducing MR while avoiding an elevated mitral valve gradient (MVG). This study assesses how multiple MitraClips used to treat MR can affect valve performance. METHODS: Six porcine mitral valves were assessed using an in vitro left heart simulator in the native, moderate-to-severe MR, and severe MR cases. MR cases were tested in the no-MitraClip, 1-MitraClip, and 2-MitraClip configurations. Mitral regurgitant fraction (MRF), MVG, and effective orifice area (EOA) were quantified. RESULTS: Native MRF, MVG, and EOA were 14.22%, 2.59 mm Hg, and 1.64 cm2, respectively. For moderate-to-severe MR, MRF, MVG, and EOA were 34.07%, 3.31 mm Hg, and 2.22 cm2, respectively. Compared with the no-MitraClip case, 1 MitraClip decreased MRF to 18.57% (P < .0001) and EOA to 1.50 cm2 (P = .0002). MVG remained statistically unchanged (3.44 mm Hg). Two MitraClips decreased MRF to 14.26% (P < .0001) and EOA to 1.36 cm2 (P = .0001). MVG remained unchanged (3.29 mm Hg). For severe MR, MRF, MVG, and EOA were 59.79%, 4.98 mm Hg, and 2.73 cm2, respectively. Compared with the no-MitraClip case, 1 MitraClip decreased MRF to 30.72% (P < .0001) and EOA to 1.82 cm2 (P < .0001); MVG remained unchanged (4.03 mm Hg). MVG remained statistically unchanged. Two MitraClips decreased MRF to 23.10% (P < .0001) and EOA to 1.58 cm2 (P < .0001); MVG remained statistically unchanged (3.82 mm Hg). Both MR models yielded no statistical difference between 1 and 2 MitraClips. CONCLUSIONS: There is limited concern regarding elevation of MVG when reducing MR using 1 or 2 MitraClips, although 2 MitraClips did not significantly continue to reduce MRF.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gooden SC, Hatoum H, Zhang W, et al. Multiple MitraClips: The balancing act between pressure gradient and regurgitation. J Thorac Cardiovasc Surg. 2020. PMID: 32711989. doi:10.1016/j.jtcvs.2020.05.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。